ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,120 filers reported holding ASTRAZENECA PLC in Q4 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $519,363 | +15.1% | 6,659 | 0.0% | 0.08% | +10.5% |
Q1 2024 | $451,171 | -3.8% | 6,659 | -4.4% | 0.08% | -11.6% |
Q4 2023 | $468,885 | -15.5% | 6,962 | -15.0% | 0.09% | -22.5% |
Q3 2023 | $554,892 | -17.7% | 8,194 | -16.3% | 0.11% | -13.3% |
Q2 2023 | $674,441 | +23.8% | 9,786 | +29.4% | 0.13% | +12.3% |
Q1 2023 | $544,711 | -0.6% | 7,560 | -6.5% | 0.11% | -9.5% |
Q4 2022 | $547,935 | +23.7% | 8,082 | 0.0% | 0.13% | +10.5% |
Q3 2022 | $443,000 | -17.8% | 8,082 | -1.0% | 0.11% | -16.2% |
Q2 2022 | $539,000 | +10.2% | 8,160 | -2.8% | 0.14% | +21.4% |
Q4 2021 | $489,000 | -6.3% | 8,394 | -3.5% | 0.11% | -8.9% |
Q3 2021 | $522,000 | +0.2% | 8,698 | +0.0% | 0.12% | -6.1% |
Q2 2021 | $521,000 | +3.0% | 8,694 | -12.7% | 0.13% | -2.2% |
Q1 2021 | $506,000 | -79.4% | 9,960 | -79.4% | 0.13% | -76.3% |
Q4 2020 | $2,455,000 | -7.1% | 48,264 | +0.1% | 0.56% | -20.2% |
Q3 2020 | $2,643,000 | +2.9% | 48,226 | -0.7% | 0.71% | -7.3% |
Q2 2020 | $2,568,000 | +18.3% | 48,547 | -0.1% | 0.76% | -9.9% |
Q1 2020 | $2,171,000 | -9.3% | 48,614 | +1.3% | 0.85% | +2.8% |
Q4 2019 | $2,393,000 | +1.0% | 48,000 | -9.7% | 0.82% | -6.7% |
Q3 2019 | $2,369,000 | +6.3% | 53,162 | -1.6% | 0.88% | +9.0% |
Q2 2019 | $2,229,000 | -5.7% | 54,003 | -7.6% | 0.81% | -6.9% |
Q1 2019 | $2,364,000 | +3.8% | 58,461 | -2.5% | 0.87% | -4.7% |
Q4 2018 | $2,277,000 | -3.9% | 59,944 | +0.1% | 0.91% | +6.0% |
Q3 2018 | $2,369,000 | +0.3% | 59,873 | -11.0% | 0.86% | +3.6% |
Q2 2018 | $2,363,000 | -7.7% | 67,291 | -8.8% | 0.83% | -22.0% |
Q1 2018 | $2,560,000 | +175.3% | 73,786 | +175.2% | 1.07% | +208.4% |
Q4 2017 | $930,000 | -63.3% | 26,810 | -64.2% | 0.35% | -63.6% |
Q3 2017 | $2,534,000 | -0.2% | 74,792 | +0.4% | 0.95% | -5.4% |
Q2 2017 | $2,540,000 | +10.4% | 74,493 | +1.1% | 1.00% | +15.7% |
Q1 2017 | $2,301,000 | -0.5% | 73,683 | +4.6% | 0.87% | -8.9% |
Q3 2016 | $2,313,000 | -99.9% | 70,426 | +8.3% | 0.95% | +10.2% |
Q1 2016 | $1,845,098,000 | +85440.0% | 65,058 | +6.0% | 0.86% | -11.8% |
Q4 2015 | $2,157,000 | +623.8% | 61,360 | +555.8% | 0.98% | +339.9% |
Q3 2015 | $298,000 | +0.3% | 9,356 | +100.4% | 0.22% | +5.2% |
Q2 2015 | $297,000 | -99.9% | 4,669 | -15.3% | 0.21% | -18.5% |
Q1 2015 | $377,118,000 | +134105.7% | 5,511 | +38.0% | 0.26% | +25.6% |
Q4 2014 | $281,000 | – | 3,994 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |